Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBK1 | Q9UHD2 | 4/20 | 0.40 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 2/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.34 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.34 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.34 |
| ▸ | CDK4 | P11802 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | MPL | P40238 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4719875 | 0.94 | MKNK1 (0.39) | TBK1HTR2CSLC6A4HTR2AACACB | |
| SCHEMBL4722378 | 0.91 | TBK1 (0.37) | TBK1ACACBGPR119CACNA1HCDK4 | |
| SCHEMBL4722370 | 0.91 | TBK1 (0.39) | TBK1HTR2CSLC6A4HTR2AACACB | |
| SCHEMBL4718652 | 0.91 | TBK1 (0.39) | TBK1ACACBGPR119CACNA1HCDK4 | |
| SCHEMBL4721977 | 0.90 | GPR119 (0.43) | TBK1GPR119 | |
| SCHEMBL4720580 | 0.89 | TBK1 (0.37) | TBK1ACACBGPR119CACNA1HAAK1 | |
| SCHEMBL389112 | 0.89 | TBK1 (0.48) | TBK1GPR119MKNK1 | |
| SCHEMBL4723185 | 0.88 | TBK1 (0.38) | TBK1ACACBGPR119MKNK1 | |
| SCHEMBL4724082 | 0.88 | TBK1 (0.38) | TBK1ACACBGPR119CACNA1HCDK4 | |
| SCHEMBL4719500 | 0.88 | ACACB (0.38) | TBK1HTR2AACACBGPR119CACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756084-B1 | SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2008-11-26 | — | — | EP | claimed |